1 | IMPROVEMENT IN KEY PSORIATIC ARTHRITIS CORE DOMAINS WITH GUSELKUMAB TREATMENT IN AN ENRICHED POPULATION OF ACR20 NONRESPONDERS AT WEEK 24: POST HOC ANALYSIS OF TWO PHASE 3 STUDIES | Coautor: Irazoque-Palazuelos, F, Mcgonagle, D, Haaland, D, Helliwell, P, et al. | 2023 | ANNALS OF THE RHEUMATIC DISEASES | WoS-id: 001107398706062
| 0 | 0 |
2 | Biological impact of iberdomide in patients with active systemic lupus erythematosus | Coautor: Irazoque-Palazuelos F., Lipsky P.E., Vollenhoven R.V., Dörner T., et al. | 2022 | ANNALS OF THE RHEUMATIC DISEASES | WoS-id: 000788577900001 Scopus-id: 2-s2.0-85130990850
| 19 | 21 |
3 | Phase 2 Trial of Iberdomide in Systemic Lupus Erythematosus | Coautor: Irazoque-Palazuelos F., Merrill J.T., Werth V.P., Furie R., et al. | 2022 | NEW ENGLAND JOURNAL OF MEDICINE | WoS-id: 000819960900009 Scopus-id: 2-s2.0-85126683538
| 60 | 69 |
4 | Efficacy and safety of switching from rituximab to biosimilar CT-P10 in rheumatoid arthritis: 72-week data from a randomized Phase 3 trial | Coautor: Irazoque-Palazuelos F., Shim S.C., Bo?ic-Majstorovic L., Berrocal Kasay A., et al. | 2019 | Rheumatology | WoS-id: 000501736300022 Scopus-id: 2-s2.0-85070068083
| 39 | 39 |
5 | Methotrexate withdrawal in patients with rheumatoid arthritis who achieve low disease activity with tofacitinib modified-release 11 mg once daily plus methotrexate (ORAL Shift): a randomised, phase 3b/4, non-inferiority trial | Coautor: Irazoque-Palazuelos F., Cohen S.B., Pope J., Haraoui B., et al. | 2019 | LANCET RHEUMATOLOGY | WoS-id: 000547821100013 Scopus-id: 2-s2.0-85078194282
| 31 | 32 |
6 | Update of the Mexican College of Rheumatology Guidelines for the Pharmacological Treatment of Rheumatoid Arthritis, 2018 | Coautor: Irazoque Palazuelos F., Cardiel M.H., Carrillo S., Pérez M., et al. | 2019 | Reumatologia Clinica | WoS-id: 000644799400008 Scopus-id: 2-s2.0-85065620063
| 10 | 10 |
7 | Comparison of biosimilar CT-P10 and innovator rituximab in patients with rheumatoid arthritis: a randomized controlled Phase 3 trial | Coautor: Irazoque-Palazuelos F., Park W., Bo?ic-Majstorovic L., Milakovic D., et al. | 2018 | MABS-AUSTIN | WoS-id: 000444570200011 Scopus-id: 2-s2.0-85050005180
| 45 | 49 |
8 | Temporomandibular joint dysfunction in patients with rheumatoid arthritis | Coautor: Irazoque-Palazuelos F., Ibáñez-Mancera N.G., Vinitzky-Brener I., Muñoz-López S., et al. | 2017 | Revista Espanola De Cirugia Oral Y Maxilofacial | Scopus-id: 2-s2.0-84991280284
| 0 | 1 |
9 | Comparing the effects of tofacitinib, methotrexate and the combination, on bone marrow oedema, synovitis and bone erosion in methotrexate-naive, early active rheumatoid arthritis: Results of an exploratory randomised MRI study incorporating semiquantitative and quantitative techniques | Coautor: Irazoque-Palazuelos F., Conaghan P.G., Østergaard M., Bowes M.A., et al. | 2016 | ANNALS OF THE RHEUMATIC DISEASES | WoS-id: 000376440900017 Scopus-id: 2-s2.0-84962179941
| 89 | 89 |
10 | Factors Associated with Mortality and Infections in Patients with Systemic Lupus Erythematosus with Diffuse Alveolar Hemorrhage | Coautor: Irazoque-Palazuelos F., Martinez-Martinez M.U., Sturbaum A.K., Alcocer-Varela J., et al. | 2014 | JOURNAL OF RHEUMATOLOGY | WoS-id: 000341824300015 Scopus-id: 2-s2.0-84905472301
| 35 | 42 |
11 | Efficacy of Tocilizumab in refractory Adult-onset Still's Disease; Report of 2 Cases [Eficacia de tocilizumab en enfermedad de Still del adulto refractaria; a propósito de 2 casos] | 2ᵒ autor: Irazoque-Palazuelos F., Andrade-Ortega L., Muñoz-López S., Rosales-Don Pablo V.M. | 2014 | Reumatologia Clinica | Scopus-id: 2-s2.0-84899916515
| 0 | 2 |
12 | Maintenance, reduction, or withdrawal of etanercept after treatment with etanercept and methotrexate in patients with moderate rheumatoid arthritis (PRESERVE): a randomised controlled trial | Coautor: Irazoque-Palazuelos F., Smolen J.S., Nash P., Durez P., et al. | 2013 | Lancet | WoS-id: 000316069700027 Scopus-id: 2-s2.0-84874983369
| 299 | 318 |
13 | Efficacy and tolerability of rituximab in patients with rhupus [Eficacia y tolerabilidad de rituximab en el tratamiento de pacientes con rhupus] | 2ᵒ autor: Irazoque-Palazuelos F., Andrade-Ortega L., Muñóz-López S., Rosales-Don Pablo V.M. | 2013 | Reumatologia Clinica | Scopus-id: 2-s2.0-84879887049
| 0 | 23 |
14 | Patient survival and safety with biologic therapy. Results of the Mexican National Registry Biobadamex 1.0 [Terapia biológica: Sobrevida y seguridad en padecimientos reumáticos. Resultados del Registro Nacional Biobadamex 1.0] | Coautor: Irazoque-Palazuelos F., Ventura-Ríos L., Bañuelos-Ramírez D., Hernández-Quiroz M.D.C., et al. | 2012 | Reumatologia Clinica | Scopus-id: 2-s2.0-84863322750
| 0 | 24 |
15 | Efficacy of rituximab versus cyclophosphamide in lupus patients with severe manifestations. A randomized and multicenter study [Eficacia de rituximab comparado con ciclofosfamida en pacientes con manifestaciones graves de lupus eritematoso g | 2ᵒ autor: Irazoque-Palazuelos F., Andrade-Ortega L., López-Villanueva R., Barragán-Navarro Y., et al. | 2010 | Reumatologia Clinica | Scopus-id: 2-s2.0-77956611409
| 0 | 20 |
16 | Epidemiology, etiology and classification [Epidemiología, etiología y clasificación] | 1ᵉʳ autor: Irazoque-Palazuelos F., Barragán-Navarro Y. | 2009 | Reumatologia Clinica | Scopus-id: 2-s2.0-71849086803
| 0 | 8 |
17 | A clinical anatomy program for rheumatology fellows, Mexico, 2007 | Coautor: Irazoque-Palazuelos, F, Canoso, JJ, Abud-Mendoza, C, Batile-Fabris, L, et al. | 2008 | ARTHRITIS AND RHEUMATISM | WoS-id: 000259244200097
| 0 | 0 |
18 | Hematomyelia in systemic lupus erythematosus and secondary antiphospholipid syndrome: Case report [Hematomielia en lupus eritematoso generalizado y síndrome antifosfolipídico secundario: Informe de un caso] | 1ᵉʳ autor: Irazoque-Palazuelos F., Sosa-Espinosa P.V., Andrade-Ortega L. | 2008 | Reumatologia Clinica | Scopus-id: 2-s2.0-42549133537
| 0 | 3 |
19 | Relapsing polychondritis: An analysis of 11 patients [Policondritis recidivante: Análisis de 11 pacientes] | Coautor: Irazoque Palazuelos F., Pérez Gudiño A.C., Lugo Zamudio G.E., Vargas Aviles A.S., et al. | 2007 | Reumatologia Clinica | Scopus-id: 2-s2.0-34548721022
| 0 | 2 |
20 | Atypical presentation and clinical course in mesangial lupus nephritis [Presentación atípica y evolución clínina de la nefropatía lúpica mesangial. Estudio de 20 pacientes] | Coautor: Irazoque-Palazuelos F., Arévalo-Martínez F.G., Andrade-Ortega L., Badía-Flores J.J. | 2006 | Reumatologia Clinica | Scopus-id: 2-s2.0-33644932767
| 0 | 4 |